Annual EBITDA
-$125.97 M
-$37.96 M-43.13%
31 December 2023
Summary:
Athira Pharma annual earnings before interest, taxes, depreciation & amortization is currently -$125.97 million, with the most recent change of -$37.96 million (-43.13%) on 31 December 2023. During the last 3 years, it has fallen by -$106.38 million (-543.15%). ATHA annual EBITDA is now -2516.16% below its all-time high of -$4.82 million, reached on 31 December 2019.ATHA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$25.25 M
+$2.54 M+9.12%
30 September 2024
Summary:
Athira Pharma quarterly earnings before interest, taxes, depreciation & amortization is currently -$25.25 million, with the most recent change of +$2.54 million (+9.12%) on 30 September 2024. Over the past year, it has increased by +$9.55 million (+27.44%). ATHA quarterly EBITDA is now -2822.57% below its all-time high of -$864.00 thousand, reached on 31 December 2019.ATHA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$110.88 M
+$9.55 M+7.93%
30 September 2024
Summary:
Athira Pharma TTM earnings before interest, taxes, depreciation & amortization is currently -$110.88 million, with the most recent change of +$9.55 million (+7.93%) on 30 September 2024. Over the past year, it has increased by +$6.15 million (+5.26%). ATHA TTM EBITDA is now -7642.95% below its all-time high of -$1.43 million, reached on 30 September 2019.ATHA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATHA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -43.1% | +27.4% | +5.3% |
| 3 y3 years | -543.1% | -61.6% | -141.0% |
| 5 y5 years | -2375.8% | -1663.3% | -7642.9% |
ATHA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -543.1% | at low | -61.6% | +27.4% | -141.0% | +12.0% |
| 5 y | 5 years | -2516.2% | at low | -2822.6% | +27.4% | -7642.9% | +12.0% |
| alltime | all time | -2516.2% | at low | -2822.6% | +27.4% | -7642.9% | +12.0% |
Athira Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$25.25 M(-9.1%) | -$110.88 M(-7.9%) |
| June 2024 | - | -$27.79 M(+1.2%) | -$120.43 M(-2.9%) |
| Mar 2024 | - | -$27.45 M(-9.7%) | -$124.04 M(-1.5%) |
| Dec 2023 | -$125.97 M(+43.1%) | -$30.40 M(-12.6%) | -$125.97 M(+7.6%) |
| Sept 2023 | - | -$34.80 M(+10.8%) | -$117.03 M(+13.4%) |
| June 2023 | - | -$31.40 M(+6.9%) | -$103.18 M(+7.0%) |
| Mar 2023 | - | -$29.38 M(+36.9%) | -$96.39 M(+9.5%) |
| Dec 2022 | -$88.01 M(+60.9%) | -$21.46 M(+2.5%) | -$88.01 M(+6.2%) |
| Sept 2022 | - | -$20.94 M(-14.9%) | -$82.86 M(+6.9%) |
| June 2022 | - | -$24.61 M(+17.2%) | -$77.55 M(+16.0%) |
| Mar 2022 | - | -$21.00 M(+28.7%) | -$66.87 M(+22.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$54.71 M(+179.3%) | -$16.32 M(+4.4%) | -$54.62 M(+18.7%) |
| Sept 2021 | - | -$15.62 M(+12.2%) | -$46.01 M(+18.5%) |
| June 2021 | - | -$13.93 M(+59.1%) | -$38.84 M(+45.2%) |
| Mar 2021 | - | -$8.75 M(+13.7%) | -$26.75 M(+36.6%) |
| Dec 2020 | -$19.59 M(+306.8%) | -$7.70 M(-9.0%) | -$19.59 M(+53.6%) |
| Sept 2020 | - | -$8.46 M(+358.6%) | -$12.75 M(+122.6%) |
| June 2020 | - | -$1.84 M(+16.2%) | -$5.73 M(+47.5%) |
| Mar 2020 | - | -$1.59 M(+83.7%) | -$3.88 M(+69.1%) |
| Dec 2019 | -$4.82 M(-5.4%) | -$864.00 K(-39.7%) | -$2.30 M(+60.3%) |
| Sept 2019 | - | -$1.43 M | -$1.43 M |
| Dec 2018 | -$5.09 M | - | - |
FAQ
- What is Athira Pharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Athira Pharma?
- What is Athira Pharma annual EBITDA year-on-year change?
- What is Athira Pharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Athira Pharma?
- What is Athira Pharma quarterly EBITDA year-on-year change?
- What is Athira Pharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Athira Pharma?
- What is Athira Pharma TTM EBITDA year-on-year change?
What is Athira Pharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ATHA is -$125.97 M
What is the all time high annual EBITDA for Athira Pharma?
Athira Pharma all-time high annual earnings before interest, taxes, depreciation & amortization is -$4.82 M
What is Athira Pharma annual EBITDA year-on-year change?
Over the past year, ATHA annual earnings before interest, taxes, depreciation & amortization has changed by -$37.96 M (-43.13%)
What is Athira Pharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ATHA is -$25.25 M
What is the all time high quarterly EBITDA for Athira Pharma?
Athira Pharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$864.00 K
What is Athira Pharma quarterly EBITDA year-on-year change?
Over the past year, ATHA quarterly earnings before interest, taxes, depreciation & amortization has changed by +$9.55 M (+27.44%)
What is Athira Pharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ATHA is -$110.88 M
What is the all time high TTM EBITDA for Athira Pharma?
Athira Pharma all-time high TTM earnings before interest, taxes, depreciation & amortization is -$1.43 M
What is Athira Pharma TTM EBITDA year-on-year change?
Over the past year, ATHA TTM earnings before interest, taxes, depreciation & amortization has changed by +$6.15 M (+5.26%)